Hematology

Infographic: Differences in Mechanism of Action and Selectivity of Covalent and Non-Covalent BTK Inhibitors. Provided by Clinical Care Options, LLC. Supported by an educational grant from Lilly.

Acute myeloid leukaemia (AML) is a rapidly progressing haematological cancer with a poor prognosis. This infographic summarises the key results from an online survey conducted in 2022 on the perceptions of AML treatments among clinicians in Europe. Haematologists and oncologists from five European countries were asked their opinions on topics such as first-line treatments, the intensity of treatment regimens, and therapies for curative intent for patients with AML.

Systemic Mastocytosis Disease Awareness Infographic: Learn more about this rare disease, its prevelance, symptoms, sub-types and diagnosis.

This year’s European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Tumours Group (CLTG) Annual Meeting was held in Madrid, Spain. Presentations covered a broad range of topics in the field of cutaneous lymphomas, from molecular mechanisms, through diagnostics and prediction of prognosis, to skin-directed and targeted therapies, combination therapies, and patient-reported outcomes.

Kakkar opened the symposium by highlighting the burden of thrombotic disease in patients with cancer with a discussion of data from the Global Anticoagulant Registry in the FIELD – Venous Thromboembolism (GARFIELD-VTE) registry.

At the International Society on Thrombosis and Haemostasis (ISTH) 2022 Congress, held 9th–13th July, multiple oral and poster presentations were dedicated to gene therapy as a treatment for haemophilia A or B.

Three posters presented at the European Hematology Association (EHA) 2022 Hybrid Congress focused on the role of mitapivat in the…

Von Willebrand disease (VWD) was first described in 1926 by Erik von Willebrand when he cared for a family member…